NR3C2 and heart failure: In most cases, treatment of DCM means heart failure therapy based on drug treatment with angiotensin-converting enzyme inhibitors (angiotensin receptor blocker or angiotensin-receptor-/neprilysin-inhibitor if applicable), beta-blockers, and mineralocorticoid-receptor antagonists according to the current heart failure guidelines [16, 58].